Frankfurt - Delayed Quote EUR

STAAR Surgical Company (SR3.F)

Compare
15.65
-0.55
(-3.36%)
As of 8:34:55 AM GMT+2. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Stephen C. Farrell CFA CEO & Lead Director 106.43k -- 1965
Mr. Warren Foust President & COO 617.72k -- 1977
Dr. Scott D. Barnes M.D. Chief Medical Officer 640.27k -- 1963
Mr. Thomas G. Frinzi Advisor 1.13M -- 1956
Ms. Deborah J. Andrews Interim Chief Financial Officer 699.7k 3.45M 1957
Mr. Brian Moore Vice President of Investor Relations & Corporate Development -- -- --
Mr. Nathaniel B. Sisitsky Esq. Senior VP, General Counsel & Corporate Secretary -- -- 1974
Ms. Nancy Sabin Chief Marketing Officer -- -- --
Mr. James Francese Senior Vice President of Commercial Operations - North America & APAC 700.02k 817.35k 1964
Dr. Magda Michna Ph.D. Chief Development Officer and Chief Clinical, Regulatory & Medical Affairs Officer -- -- --

STAAR Surgical Company

25510 Commercentre Drive
Lake Forest, CA 92630
United States
626 303 7902 https://www.staar.com
Sector: 
Healthcare
Full Time Employees: 
1,157

Description

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Corporate Governance

STAAR Surgical Company’s ISS Governance QualityScore as of April 1, 2025 is 8. The pillar scores are Audit: 9; Board: 3; Shareholder Rights: 7; Compensation: 10.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 5, 2025 at 10:59 AM UTC - May 9, 2025 at 12:00 PM UTC

STAAR Surgical Company Earnings Date

Recent Events